Introducing Wockhardt UK

About Us

International growth is fundamental to the Wockhardt corporate strategy. In the UK, this led to the acquisition of The Wallis Laboratory in 1997, followed by CP Pharmaceuticals during 2003.

The merger of these two companies created Wockhardt UK.

This merger produced a diverse pharmaceutical business, capable of supplying healthcare products to the Retail Pharmacy, Hospital and Grocery sectors. With thriving Export and Contract Manufacturing Divisions also in place this is an exciting time for Wockhardt UK.

With the global strength of our parent company behind us, the UK business is benefiting from significant financial investment.

Innovation
Supported by Wockhardt’s multidisciplinary research programme and impressive product pipeline, we are set for growth.

Excellence
Management systems are continually being improved. The implementation of new Supply Chain technology is already underway in order to maximise product availability and streamline distribution.

People
We believe that people are the mainstay of our organisation. Ongoing investment in training ensures that experienced team members are on hand throughout the company.

Our philosophy is to create value by combining the needs of the customer with an uncompromising drive for excellence.